Pricing Log in Create free account

Cibus, Inc. (CBUS) vs Polaryx Therapeutics, Inc. (PLYX)

Cibus, Inc. and Polaryx Therapeutics, Inc. are both Biotechnology companies. Cibus, Inc. and Polaryx Therapeutics, Inc. are of similar size ($87.1M and $86.7M). Polaryx Therapeutics, Inc. has the higher net margin (0.00% vs −2,258.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Polaryx Therapeutics, Inc. leads on 9 and Cibus, Inc. on 3.

Valuation

Metric CBUS PLYX Biotechnology median
P/E n/m n/m 10.60
P/S 20.66 n/m 9.40
P/B 6.07 8.12 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 16.20 n/m 9.02
Earnings yield (141.03%) (11.77%) (32.88%)
Free cash flow yield (51.53%) (9.27%) (23.13%)

Profitability

Metric CBUS PLYX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (1,450.59%) 0.00% 0.00%
Net margin (2,258.89%) 0.00% 0.00%
Free cash flow margin (1,064.60%) 0.00% 0.00%
Return on equity (219.97%) 0.00% (51.96%)
Return on assets (29.77%) (169.05%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CBUS PLYX Biotechnology median
Revenue growth (TTM) (10.30%) — 6.76%
EPS growth (last fiscal year) 74.33% 77.72% 29.88%
Revenue growth, 5-year CAGR (31.34%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CBUS PLYX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.62 13.53 4.97
Net debt to EBITDA (0.28) 0.66 1.01

Dividend

Metric CBUS PLYX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CBUS PLYX Biotechnology median
Market cap 87.13m 86.73m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack